compound introduction
Dutogliptin (PHX-1149 free base) is an orally available, potent, and selective dipeptidyl peptidase-4 ( DPP4 ) inhibitor for the treatment of type 2 diabetes mellitus. In Vivo Dutogliptin exhibits low plasma protein binding (11%) and is rapidly absorbed with a T max of 3-4 h and a half-life of 10-13 h. Dutogliptin is metabolically stable and does not inhibit or induce the activity of major CYP450s. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:DPP4
